Clinical Trials Browser

OTHER × Decitabine × Gastrointestinal × Clear all

NCT07007767 2025-06-06

Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）

Phase 2 Not yet recruiting

Gastrointestinal

Colorectal Cancer Metastatic

NCT05360264 2025-03-24

ORIENTATE

Phase 2 Terminated

Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT01882660 2022-12-19

DECO

Phase NA Terminated

Gastrointestinal

Colonic Neoplasms

NCT05265962 2022-03-04

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02847000 2019-01-09

p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer

Phase EARLY_PHASE1 Completed

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT02685228 2016-02-18

SLOWDOSE001

Phase NA Unknown

Gastrointestinal

Pancreatic Neoplasms